The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Urges Caution with Steroid Injections for Hip Osteoarthritis

Study Urges Caution with Steroid Injections for Hip Osteoarthritis

April 26, 2018 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Nikolay Litov / shutterstock.com

Nikolay Litov / shutterstock.com

For patients with hip osteoarthritis (OA), pain management and maintaining function are primary therapy goals. Current guidelines offer recommendations on nonpharmacologic and pharmacologic approaches to addressing these issues in hip OA.

You Might Also Like
  • Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain
  • Steroid Injections for Lateral Epicondylalgia Worse than Placebo in Long Term
  • Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk
Explore This Issue
April 2018
Also By This Author
  • New Study Sheds Light on Deficiency of Adenosine Deaminase 2 (DADA2)

For patients in whom pharmacologic management is considered, the use of intra-articular steroid injections is one option. In its 2012 guidelines (the most current available) the ACR gave the use of intra-articular corticosteroid injections a conditional recommendation for the initial management of OA.1 Evidence in support of that recommendation was based largely on data extrapolated from studies that looked at the use of steroid injections for knee OA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In a study published in 2016, McCabe and colleagues conducted a literature review of the evidence for the use of intra-articular steroids for hip OA.2 Based on five studies, the investigators found that steroid injections in hip OA may be efficacious in the short term to reduce pain. However, they emphasized again that the evidence on which this outcome is based remains relatively poor and called for larger, rigorous trials to verify the true efficacy of steroid injections for hip OA.

Into this dearth of evidence on the true efficacy of steroid injections for hip OA comes a study cautioning that such injections may actually be deleterious and may spur osteonecrosis and bone collapse.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Connie Y. Chang, MD, a radiologist at Massachusetts General Hospital and assistant professor of radiology at Harvard Medical School, Boston, presented results of the study in November 2017 at the Radiological Society of North America (RSNA) Annual Meeting.3

Bone Death & Collapse

The study included three groups of patients: 102 patients with hip OA treated by steroid injections (intervention group) who underwent radiologic imaging of the hip at the time of injection; 102 patients with hip OA who underwent radiologic imaging but were not treated by steroid injections (control group); and 44 patients who underwent imaging and were treated by steroid injections in the shoulder (control group). All patients underwent a second imaging at three–nine months’ follow-up. Patients in the control groups matched the demographics of those in the intervention group, which included 62 women ranging in age from 19–92 years.

Connie Y. Chang, MD, and research team

Connie Y. Chang, MD, and research team

To assess whether steroid injections for hip OA would worsen osteoarthritis, two musculoskeletal radiologists independently performed a retrospective blinded review of the radiographs taken before and after the steroid injections in the patients in the intervention group, as well as of the radiographs of the two control groups.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Osteoarthritis Tagged With: hip, steroid injectionIssue: April 2018

You Might Also Like:
  • Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain
  • Steroid Injections for Lateral Epicondylalgia Worse than Placebo in Long Term
  • Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk
  • Letters: A Word of Caution on Colchicine Study

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.